These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1324142)

  • 21. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.
    Shuck JW; Oetgen WJ; Tesar JT
    Am J Med; 1985 Feb; 78(2):221-7. PubMed ID: 3970048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.
    Camilleri M; Brown ML; Malagelada JR
    Gastroenterology; 1986 Sep; 91(3):619-26. PubMed ID: 3525315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical aspects of systemic and localized scleroderma.
    van den Hoogen FH; de Jong EM
    Curr Opin Rheumatol; 1995 Nov; 7(6):546-50. PubMed ID: 8579977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal cardiovascular autonomic function in patients with systemic sclerosis (CREST variant).
    Suarez-Almazor ME; Bruera E; Russell AS
    Ann Rheum Dis; 1988 Aug; 47(8):672-4. PubMed ID: 3415366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis.
    Basilisco G; Barbera R; Vanoli M; Bianchi P
    Dig Dis Sci; 1993 Aug; 38(8):1525-9. PubMed ID: 8344111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive radionuclide esophagogastrointestinal transit study: methodology, reference values, and initial clinical experience.
    Antoniou AJ; Raja S; El-Khouli R; Mena E; Lodge MA; Wahl RL; Clarke JO; Pasricha P; Ziessman HA
    J Nucl Med; 2015 May; 56(5):721-7. PubMed ID: 25766893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonic transit disorders in systemic sclerosis.
    Wang SJ; Lan JL; Chen DY; Chen YH; Hsieh TY; Lin WY
    Clin Rheumatol; 2001; 20(4):251-4. PubMed ID: 11529630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal transit in patients with systemic sclerosis.
    Fynne L; Worsøe J; Gregersen T; Schlageter V; Laurberg S; Krogh K
    Scand J Gastroenterol; 2011 Oct; 46(10):1187-93. PubMed ID: 21815862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis.
    Majewski S; Skopinska-Rozewska E; Jablonska S; Polakowski I; Pawinska M; Marczak M; Szmurlo A
    Arthritis Rheum; 1985 Oct; 28(10):1133-9. PubMed ID: 2413869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects.
    Edelbroek MA; Horowitz M; Wishart JM; Akkermans LM
    J Nucl Med; 1993 Apr; 34(4):582-8. PubMed ID: 8455074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis.
    Taylor CJ; Hillel PG; Ghosal S; Frier M; Senior S; Tindale WB; Read N
    Arch Dis Child; 1999 Feb; 80(2):149-52. PubMed ID: 10325730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of progressive systemic sclerosis on gastric emptying].
    Jonderko G; Gołab T; Kucharz E; Rubisz-Brzezińska J; Jedrocha W; Polanowicz U; Kurkowski L
    Pol Arch Med Wewn; 1993 Jul; 90(1):13-8. PubMed ID: 8234000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ileocecal segment transposition does not alter whole gut transit in humans.
    Degen LP; von Flüe MO; Collet A; Hamel C; Beglinger C; Harder F
    Ann Surg; 1997 Dec; 226(6):746-51; discussion 751-2. PubMed ID: 9409573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olestra, a nondigestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit.
    Aggarwal AM; Camilleri M; Phillips SF; Schlagheck TG; Brown ML; Thomforde GM
    Dig Dis Sci; 1993 Jun; 38(6):1009-14. PubMed ID: 8508694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal Transit Time in Parkinson's Disease Using a Magnetic Tracking System.
    Knudsen K; Haase AM; Fedorova TD; Bekker AC; Østergaard K; Krogh K; Borghammer P
    J Parkinsons Dis; 2017; 7(3):471-479. PubMed ID: 28759975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrobiliary motility after liquid fatty meal in progressive systemic sclerosis. A sonographic study.
    Wedmann B; Wegener M; Adamek RJ; el Gammal S
    Dig Dis Sci; 1994 Mar; 39(3):565-70. PubMed ID: 8131694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets.
    Burton DD; Camilleri M; Mullan BP; Forstrom LA; Hung JC
    J Nucl Med; 1997 Nov; 38(11):1807-10. PubMed ID: 9374360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding gastric telangiectasia. Complication of Raynaud's phenomenon, esophageal motor dysfunction, sclerodactyly and telangiectasia (REST) syndrome.
    Allende HD; Ona FV; Noronha AI
    Am J Gastroenterol; 1981 May; 75(5):354-6. PubMed ID: 7270529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cisapride on colonic transit in patients with progressive systemic sclerosis.
    Wang SJ; Lan JL; Lan JL; Chen DY; Chen YH; Hsieh TY; Lin WY
    Clin Rheumatol; 2002 Aug; 21(4):271-4. PubMed ID: 12189451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.